SAPNA PRADYUMAN PATEL to Nausea
This is a "connection" page, showing publications SAPNA PRADYUMAN PATEL has written about Nausea.
Connection Strength
0.054
-
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors. Clin Cancer Res. 2019 11 01; 25(21):6309-6319.
Score: 0.036
-
The safety of temozolomide in the treatment of malignancies. Expert Opin Drug Saf. 2009 Jul; 8(4):493-9.
Score: 0.018